Last reviewed · How we verify
placebo tablet of DLBS1033 — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
placebo tablet of DLBS1033 (placebo tablet of DLBS1033) — Dexa Medica Group. A placebo tablet containing no active pharmaceutical ingredient, used as a control comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| placebo tablet of DLBS1033 TARGET | placebo tablet of DLBS1033 | Dexa Medica Group | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- placebo tablet of DLBS1033 CI watch — RSS
- placebo tablet of DLBS1033 CI watch — Atom
- placebo tablet of DLBS1033 CI watch — JSON
- placebo tablet of DLBS1033 alone — RSS
Cite this brief
Drug Landscape (2026). placebo tablet of DLBS1033 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-tablet-of-dlbs1033. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab